Approvals/TGA/SEQUASE XR quetiapine (as fumarate) 300 mg modified release tablet blister pack

Approved

STANDARD

SEQUASE XR quetiapine (as fumarate) 300 mg modified release tablet blister pack

Luye Pharma Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: bcad9b0b2e5ed565
Product Name: SEQUASE XR quetiapine (as fumarate) 300 mg modified release tablet blister pack
Artg Id: 212514
Artg Name: SEQUASE XR quetiapine (as fumarate) 300 mg modified release tablet blister pack
Sponsor: Luye Pharma Australia Pty Ltd
Company Detail Path: /organization/luye-pharma-australia-pty-ltd
Artg Date: 2014-07-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-02449-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-02657-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

bcad9b0b2e5ed565

Type

Standard